Cyclerion Therapeutics (CYCN) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to -$23000.0.
- Cyclerion Therapeutics' Other Gross PP&E Adjustments rose 8321.17% to -$23000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$23000.0, marking a year-over-year increase of 8321.17%. This contributed to the annual value of -$7.0 million for FY2024, which is 73.43% down from last year.
- Cyclerion Therapeutics' Other Gross PP&E Adjustments amounted to -$23000.0 in Q3 2025, which was up 8321.17% from -$80000.0 recorded in Q2 2025.
- Cyclerion Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $909000.0 during Q1 2022, with a 5-year trough of -$40.7 million in Q1 2021.
- Over the past 5 years, Cyclerion Therapeutics' median Other Gross PP&E Adjustments value was -$189000.0 (recorded in 2024), while the average stood at -$3.8 million.
- As far as peak fluctuations go, Cyclerion Therapeutics' Other Gross PP&E Adjustments surged by 10796.88% in 2022, and later plummeted by 48101.27% in 2024.
- Quarter analysis of 5 years shows Cyclerion Therapeutics' Other Gross PP&E Adjustments stood at -$6.8 million in 2021, then dropped by 8.07% to -$7.4 million in 2022, then rose by 6.03% to -$6.9 million in 2023, then decreased by 0.73% to -$7.0 million in 2024, then soared by 99.67% to -$23000.0 in 2025.
- Its Other Gross PP&E Adjustments was -$23000.0 in Q3 2025, compared to -$80000.0 in Q2 2025 and -$363000.0 in Q1 2025.